Article Abstract

Survival implications of transbronchial cryobiopsy and other diagnostic modalities in idiopathic pulmonary fibrosis

Authors: Jasleen K. Pannu, Justin C. Hewlett, Aaron B. Smith, Wendi R. Mason, Heidi Chen, Otis B. Rickman, Robert J. Lentz, Jonathan A. Kropski, Fabien Maldonado


Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive fibrotic lung disease with a median survival of only 2 to 3 years (1). Approximately half of IPF diagnoses are established by characteristic features on high resolution computerized tomographic scan of the chest (HRCT).